U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 5

1.
Figure 4

Figure 4. From: Melatonin Effects in Methylphenidate Treated Children with Attention Deficit Hyperactivity Disorder: A Randomized Double Blind Clinical Trial.

Mean total sleep latency (minute) of two trial groups on SDSC sleep questionnaire at baseline, 2, 4 and 8 weeks after the treatment using ANOVA with repeated measures.

Mohammad Reza Mohammadi, et al. Iran J Psychiatry. 2012 Spring;7(2):87-92.
2.
Figure 2

Figure 2. From: Melatonin Effects in Methylphenidate Treated Children with Attention Deficit Hyperactivity Disorder: A Randomized Double Blind Clinical Trial.

Mean hyperactivity scores of two trial groups based on ADHD rating scale at baseline, 2, 4 and 8 weeks after the treatment using ANOVA with repeated measures.

Mohammad Reza Mohammadi, et al. Iran J Psychiatry. 2012 Spring;7(2):87-92.
3.
Figure 5

Figure 5. From: Melatonin Effects in Methylphenidate Treated Children with Attention Deficit Hyperactivity Disorder: A Randomized Double Blind Clinical Trial.

Mean total sleep score of two trial groups on SDSC sleep questionnaire at baseline, 2, 4 and 8 weeks after the treatment using ANOVA with repeated measures.

Mohammad Reza Mohammadi, et al. Iran J Psychiatry. 2012 Spring;7(2):87-92.
4.
Figure 3

Figure 3. From: Melatonin Effects in Methylphenidate Treated Children with Attention Deficit Hyperactivity Disorder: A Randomized Double Blind Clinical Trial.

Mean total sleep duration (hour) of two trial group on SDSC sleep questionnaire at baseline, 2, 4 and 8 weeks after the treatment using ANOVA with repeated measures.

Mohammad Reza Mohammadi, et al. Iran J Psychiatry. 2012 Spring;7(2):87-92.
5.
Figure 1

Figure 1. From: Melatonin Effects in Methylphenidate Treated Children with Attention Deficit Hyperactivity Disorder: A Randomized Double Blind Clinical Trial.

Mean attention deficiency scores of two trial groups based on ADHD (attention-deficit hyperactivity disorder) rating scale at baseline, 2, 4 and 8 weeks after the treatment using ANOVA with repeated measures

Mohammad Reza Mohammadi, et al. Iran J Psychiatry. 2012 Spring;7(2):87-92.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center